Asian Phytoceuticals Public Company Limited

APCO reported its Q2/2026 financial results with total revenue of 44.25 million baht and net profit of 11.06 million baht. The company continues to capitalize on the longevity trend by launching the new Mylife100A formula, which features anti-aging and holistic health restoration benefits. The information was provided by Professor Dr. Pichet Viriyachitra, Chief Executive Officer. The company is also expanding its consumer base through BIM Advisor. The details were disclosed at the Opportunity Day event organized by the Stock Exchange of Thailand, and the recording can be viewed at www.set.or.th/streaming/vdos-oppday.

APCO is preparing to hold further discussions with partners in Africa regarding orders and delivery plans for the first batch of mylife100 products, following the signing of distribution contracts for approximately 1.5 million bottles per year in the UAE and Africa. The company expects clarity on the first batch delivery in early September 2026, with shipments beginning by the end of this year, which will support a strong performance in the fourth quarter of 2026. For the full year 2026, the company maintains its revenue estimate of 216 million baht, similar to 2025, after generating 93.81 million baht in the first half. If deliveries proceed as agreed in 2027, overseas sales, which currently account for only 5% of total sales, could grow sevenfold. The company will also continue expanding the domestic market through BIM Advisor.